Condition: Paralysis, Unilateral, Vocal Cord · Sponsor: APrevent Biotech GmbH
This is a prospective, 2-part, multi-center, open-label, non-randomized clinical trial to assess safety and effectiveness of APrevent® VOIS Implants for the treatment of patients with Unilateral Vocal Fold Paralysis (UVFP). In total 30 evaluable patients are planned to be enrolled.
This description comes directly from the study's public registry record.
Berit Schneider-Stickler, Prof · + 43-676-842 311 311 · office@med4com.at
Matthias Leonhard, Dr · +43 1 404 00 - 33170 · matthias.leonhard@meduniwien.ac.at
Always discuss trial participation with your own doctor first.
| Mayo Clinic - Phoenix | Phoenix, Arizona, United States | Recruiting |
| Greater Baltimore Medical Center | Baltimore, Maryland, United States | Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Not Yet Recruiting |
| The University of Texas Health Science Center at Houston | Houston, Texas, United States | Recruiting |
| Medical University of Vienna | Vienna, Austria | Recruiting |
| SRH Wald-Klinikum Gera | Gera, Germany | Recruiting |
| University Medical Center | Hamburg, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05119842